10,406
Total Claims
$759K
Drug Cost
682
Beneficiaries
$1,113
Cost/Patient
Peer Comparison vs. 110,156 Internal Medicine providers
-21%
Cost per patient vs peers
$1,113 vs $1,411 avg
+3%
Brand preference vs peers
10.9% vs 10.6% avg
Brand vs Generic
89% generic
Brand: 1,122 claims · $593K
Generic: 9,162 claims · $159K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 126 | $97K |
| Dulaglutide | 42 | $72K |
| Empagliflozin | 51 | $55K |
| Rivaroxaban | 37 | $40K |
| Insulin Aspart | 20 | $35K |
| Sitagliptin Phosphate | 28 | $35K |
| Semaglutide | 29 | $34K |
| Insulin Glargine,hum.Rec.Anlog | 39 | $27K |
| Insulin Detemir | 13 | $17K |
| Insulin Lispro | 15 | $14K |
| Lipase/Protease/Amylase | 11 | $12K |
| Budesonide/Formoterol Fumarate | 24 | $12K |
| Tirzepatide | 11 | $11K |
| Atorvastatin Calcium | 645 | $8,185 |
| Levothyroxine Sodium | 496 | $7,060 |
Prescribing Profile
Patient Profile
73
Avg Age
46%
Female
1.09
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data